Bruker Corp

Bruker Corp

BRKR

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.13B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bruker CorpBruker Corp-76.40.37%-3%2.51
$61.25

Target Price by Analysts

9.9% upsideBruker Target Price DetailsTarget Price
$9.75

Current Fair Value

82.5% downside

Overvalued by 82.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.13 Billion
Enterprise Value$10.31 Billion
Dividend Yield$0.20 (0.37%)
Earnings per Share$-0.15
Beta1.26
Outstanding Shares152,200,000

Return

Return on Equity-2.97%ROE
Return on Assets-1.18%
Return on Invested Capital0.51%

Valuation & Multiples

P/E Ratio-76.44P/E Ratio
PEG9.75PEG
Price to Sales2.53Price to Sales
Price to Book Ratio3.72Price to Book Ratio
Enterprise Value to Revenue2.95
Enterprise Value to EBIT420.77
Enterprise Value to Net Income-145
Total Debt to Enterprise0.23
Debt to Equity0.98Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectation
Revenue Estimate
$853.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.42
Average shareholder expectation
Revenue Estimate
$867.38 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1234 65.42%
Total Calls1,536,900 609.23%
Total Puts189,600 12.52%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %94.39% 4.42%
Total Invested$8.60B 73.99%
Investors Holding432 79.00%

ESG Score

No data

About Bruker Corp

6,000 employees
CEO: Frank Laukien

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...